Long-Term Debt (Details) (USD $)
|
0 Months Ended | 12 Months Ended | |
---|---|---|---|
Oct. 31, 2014
|
Dec. 31, 2014
|
Oct. 31, 2014
installment
|
|
Debt Instrument [Line Items] | |||
Legal Fees | $ 300,000us-gaap_LegalFees | ||
Notes Payable, Other Payables | |||
Debt Instrument [Line Items] | |||
Subordinated note payable |
11,000,000us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableOtherPayablesMember |
||
Long-term debt |
7,500,000us-gaap_LongTermDebt / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableOtherPayablesMember |
||
RedPath Integrated Pathology, Inc | Notes Payable, Other Payables | |||
Debt Instrument [Line Items] | |||
Face amount |
11,000,000us-gaap_DebtInstrumentFaceAmount / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableOtherPayablesMember |
11,000,000us-gaap_DebtInstrumentFaceAmount / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableOtherPayablesMember |
|
Stated interest rate |
5.00%us-gaap_DebtInstrumentInterestRateStatedPercentage / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableOtherPayablesMember |
5.00%us-gaap_DebtInstrumentInterestRateStatedPercentage / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableOtherPayablesMember |
|
Subordinated note payable |
7,396,000us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableOtherPayablesMember |
||
Interest Expense |
100,000us-gaap_InterestExpenseDebt / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableOtherPayablesMember |
||
Long-term debt |
7,300,000us-gaap_LongTermDebt / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableOtherPayablesMember |
||
Number of equal consecutive quarterly installments |
8pdii_DebtInstrumentNumberofEqualConsecutiveQuarterlyInstallments / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableOtherPayablesMember |
8pdii_DebtInstrumentNumberofEqualConsecutiveQuarterlyInstallments / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableOtherPayablesMember |
|
RedPath Integrated Pathology, Inc | Loans | |||
Debt Instrument [Line Items] | |||
Face amount |
20,000,000us-gaap_DebtInstrumentFaceAmount / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_LongtermDebtTypeAxis = us-gaap_LoansMember |
20,000,000us-gaap_DebtInstrumentFaceAmount / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_LongtermDebtTypeAxis = us-gaap_LoansMember |
|
Stated interest rate |
1.00%us-gaap_DebtInstrumentInterestRateStatedPercentage / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_LongtermDebtTypeAxis = us-gaap_LoansMember |
1.00%us-gaap_DebtInstrumentInterestRateStatedPercentage / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_LongtermDebtTypeAxis = us-gaap_LoansMember |
|
Margin on interest rate |
12.50%us-gaap_DebtInstrumentBasisSpreadOnVariableRate1 / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_LongtermDebtTypeAxis = us-gaap_LoansMember |
||
Interest rate, increase in case of default |
3.00%us-gaap_DebtInstrumentInterestRateIncreaseDecrease / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_LongtermDebtTypeAxis = us-gaap_LoansMember |
||
Proceeds from issuance of debt |
19,600,000us-gaap_ProceedsFromIssuanceOfDebt / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_LongtermDebtTypeAxis = us-gaap_LoansMember |
||
Debt issuance cost |
100,000us-gaap_DebtIssuanceCosts / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_LongtermDebtTypeAxis = us-gaap_LoansMember |
||
Interest Expense |
100,000us-gaap_InterestExpenseDebt / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_LongtermDebtTypeAxis = us-gaap_LoansMember |
||
Long-term debt |
19,700,000us-gaap_LongTermDebt / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_LongtermDebtTypeAxis = us-gaap_LoansMember |
||
Loan Processing Fee |
300,000us-gaap_LoanProcessingFee / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_LongtermDebtTypeAxis = us-gaap_LoansMember |
||
Exit Fee |
800,000pdii_DebtInstrumentExitFee / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_LongtermDebtTypeAxis = us-gaap_LoansMember |
||
Prepayment premium, base amount |
80,000,000pdii_DebtInstrumentPrepaymentPremiumBaseAmount / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_LongtermDebtTypeAxis = us-gaap_LoansMember |
||
Maximum | RedPath Integrated Pathology, Inc | |||
Debt Instrument [Line Items] | |||
Maximum quarterly principal payment |
$ 250,000us-gaap_DebtInstrumentPeriodicPaymentPrincipal / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_RangeAxis = us-gaap_MaximumMember |
||
Molecular Diagnostics | Maximum | RedPath Integrated Pathology, Inc | |||
Debt Instrument [Line Items] | |||
Quarterly revenue based payments, percent of net sales |
1.25pdii_DebtInstrumentQuarterlyRevenueBasedPaymentsPercentofNetSales / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_ProductOrServiceAxis = pdii_MolecularDiagnosticsMember / us-gaap_RangeAxis = us-gaap_MaximumMember |
||
On or After October 31, 2015 | RedPath Integrated Pathology, Inc | Loans | |||
Debt Instrument [Line Items] | |||
Prepayment fee percent |
6.00%pdii_DebtInstrumentPrepaymentFeePercent / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_LongtermDebtTypeAxis = us-gaap_LoansMember / pdii_PrepaymentDateAxis = pdii_DateRangeOneMember |
||
Between October 31, 2016 and October 31, 2017 | RedPath Integrated Pathology, Inc | Loans | |||
Debt Instrument [Line Items] | |||
Prepayment fee percent |
5.00%pdii_DebtInstrumentPrepaymentFeePercent / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_LongtermDebtTypeAxis = us-gaap_LoansMember / pdii_PrepaymentDateAxis = pdii_DateRangeTwoMember |
||
Prepayment premium |
1.25%pdii_DebtInstrumentPrepaymentPremium / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_LongtermDebtTypeAxis = us-gaap_LoansMember / pdii_PrepaymentDateAxis = pdii_DateRangeTwoMember |
||
Between October 31, 2007 and October 31, 2008 | RedPath Integrated Pathology, Inc | Loans | |||
Debt Instrument [Line Items] | |||
Prepayment fee percent |
2.00%pdii_DebtInstrumentPrepaymentFeePercent / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_LongtermDebtTypeAxis = us-gaap_LoansMember / pdii_PrepaymentDateAxis = pdii_DateRangeThreeMember |
X | ||||||||||
- Definition
Debt Instrument, Exit Fee No definition available.
|
X | ||||||||||
- Definition
Debt Instrument, Number of Equal Consecutive Quarterly Installments No definition available.
|
X | ||||||||||
- Definition
Debt Instrument, Prepayment Fee, Percent No definition available.
|
X | ||||||||||
- Definition
Debt Instrument, Prepayment Premium No definition available.
|
X | ||||||||||
- Definition
Debt Instrument, Prepayment Premium, Base Amount No definition available.
|
X | ||||||||||
- Definition
Debt Instrument, Quarterly Revenue Based Payments, Percent of Net Sales No definition available.
|
X | ||||||||||
- Definition
Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Percentage points added to the reference rate to compute the variable rate on the debt instrument. No definition available.
|
X | ||||||||||
- Definition
Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Incremental percentage increase (decrease) in the stated rate on a debt instrument. No definition available.
|
X | ||||||||||
- Definition
Contractual interest rate for funds borrowed, under the debt agreement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Amount of the required periodic payments applied to principal. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of debt issuance costs (for example, but not limited to, legal, accounting, broker, and regulatory fees). No definition available.
|
X | ||||||||||
- Definition
Amount of the cost of borrowed funds accounted for as interest expense for debt. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Expenses paid for obtaining loans which includes expenses such as application and origination fees. No definition available.
|
X | ||||||||||
- Definition
Carrying amount of long-term debt, net of unamortized discount or premium, including current and noncurrent amounts. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|